RME Hot Seat: Immunotherapy for Multiple Myeloma
| Overview / Abstract: |
The number and type of treatments for multiple myeloma continue to expand rapidly. The emergence of several new immunotherapy options holds particular promise for patients with relapsed/refractory myeloma, but effectively integrating these approaches into practice remains a significant challenge. Developed for oncology nurses and advanced practitioners, this RME Hot Seat provides a virtual Q&A with a panel of experts who field a range of questions on the use of antibody-based therapies, bispecific T-cell engagers, chimeric antigen receptor T–cell therapy, and other new and emerging immunotherapeutic options for myeloma patient care. |
|
Expiration |
Jan 04, 2022 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE |
|
Format |
Online |
|
Credits / Hours |
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is approved for 1.0 Nursing Contact Hour. |
|
Accreditation |
ANCC |
|
Presenters / Authors / Faculty |
Colleen Harker Erb, MSN, CRNP, ACNP-BC, AOCNP Angela M. Vickroy, ANP-BC, OCN |
|
Activity Specialities / Related Topics |
Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc; and Sanofi Genzyme. |
|
Keywords / Search Terms |
RedMedEd RedMedEd RedMedEd Free, Nursing, Nurse, Rush, Multiple Myeloma Research Foundation, RedMedEd MMRF, MM, multiple myeloma, myeloma, disease, CNE, nurse, nursing, free, Free CE, myeloma patients, T-cell, emerging, immunotherapeutic options, myeloma patient care, relapsed, relapsed/refractory, immunotherapy, practice, bispecific T-cell Free CE CME |
|